ReviewJSES international2025
Reverse total shoulder arthroplasty in younger patients.
Review in JSES international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Primary reverse total shoulder arthroplasty in patients aged ≤65 years: a systematic review and meta-analysis.JSES reviews, reports, and techniques · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The utility of reverse total shoulder arthroplasty (rTSA) in younger patients has been long debated. Initial rTSA designs were highly constrained and led to increased rates of failure in the literature. This garnered concerns regarding implant longevity and the need for complex revision surgery in young and active patients. Thus, rTSA was reserved for older patients with decreased upper-extremity demand. However, recent advancements in both rTSA design and techniques have demonstrated promise for rTSA in young and active patients. Various techniques, including glenoid lateralization, humeral lateralization, and tendon transfers, aim to restore shoulder function and range of motion. Furthermore, patient-specific characteristics and comorbidities may be more valuable predictors of long-term success following rTSA compared to age, which has been arbitrarily defined in the literature.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.